Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Cardiol Therapeutics Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 1.16M | 1.13M | −27.4K (−2.4%) |
| Value | $5.09M | $3.37M | −$1.73M (−33.9%) |
New holders (0)
Institutions that held Cardiol Therapeutics Inc. at the end of Q2 2021 but not at the end of Q1 2021.
None.
Sold out (0)
Institutions that held Cardiol Therapeutics Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.